Heart failure: The Cinderella of cardiology?

Public Health

Volumn 110, Issue 6, 1996, Pages 351-355

  McKinnon, M E ^a   McKee, C M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Diagnostic criteria; Heart failure; Prevalence; Women

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; VASODILATOR AGENT;

ARTICLE; HEART FAILURE; HUMAN; MORTALITY; PRIMARY HEALTH CARE; QUALITY OF LIFE;

EID: 0029803011     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(96)80007-2     Document Type: Article

References (64)

1. Dargie HJ, McMurray. Diagnosis and management of heart failure BMJ 1994; 308: 321-328.
2. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation in treatment of patients with heart failure Br Heart J 1994; 71: 584-587.
3. Vasan RJ, Benjamine EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective J Am Coll Cardiol 1995; 26: 1565-1574.
4. Jackson G. Coronary artery disease and women BMJ 1994; 309: 555.
5. Simon PM et al. Distinguishable types of dyspnoea in patients with shortness of breath Am Rev Respir Dis 1990; 142: 1009-1014.
6. Davis M et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 1994; 343: 440-444.
7. Dutka DP et al. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure Eur Heart J 1995; 16: 1223-1230.
8. Bittner V et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction JAMA 1993; 270: 1702-1707.
9. Friedman MM, King KB. Correlates of fatigue in older women with heart failure Heart Lung 1995; 24: 512-518.
10. Kannel WB, Belanger AJ. Epidemiology of heart failure Am Heart J 1991; 121: 951-978.
11. Seager LH. Congestive heart failure. Consideration for primary care physicians Postgrad Med 1995; 98: 127-137.
12. McFate-Smith W. Epidemiology of congestive heart failure Am J Cardiol 1985; 55: 3A-8A.
13. Kalon KL, Pinsky JL, Kannell WB, Levy D. The epidemiology of heart failure: Framingham Study J Am Coll Cardiol 1993; 22: 6A-13A.
14. Schocken DD, Arrieta MJ, Leaverton PE. Prevalence and mortality rate of congestive heart failure in the United States J Am Coll Cardiol 1992; 20: 301-306.
15. Eriksson H et al. Risk factors for heart failure in the general population: The study of men born in 1913 Eur Heart J 1989; 10: 647-656.
16. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986 Arch Intern Med 1990; 150: 769-773.
17. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham study J Am Coll Cardiol 1990; 22: 6A-13A.
18. Parameshawar J, Poole-Wilson PA, Sutton GC. Heart failure in a district general hospital J Roy Coll of Physicians 1992; 26: 139-142.
19. Parameshawar J et al. Prevalence of heart failure in three general practices in north west London Br J Gen Practice 1992; 42: 287-289.
20. Remes J, Reunanen A, Aromaa A, Pyorala K. Incidence of heart failure in eastern Finland. A population based surveillance study Eur Heart J 1992; 13: 588-595.
21. Gillum RF. Epidemiology of heart failure in the United States Am Heart J 1993; 126: 1042-1047.
22. Rodeheffer RJ et al. The incidence and prevalence of congestive heart failure in Rochester Minnesota Mayo Clinic Proc 1993; 68: 1143-1150.
23. Doughty R, Yee T, Sharpe N, MacMahon S. Hospital admissions and death due to congestive heart failure in New Zealand 1988-91 N-Z Med J 1995; 108: 473-475.
24. Sanderson JE et al. The aetiology of heart failure in the Chinese population of Hong Kong - a prospective study of 730 consecutive patients Int J Cardiol 1995; 51: 29-35.
25. Stephenson P, McKee M. Look Twice Eur J Public Health 1993; 3: 18-21.
26. Angel M. Caring for women's health - what is the problem? New Engl J Med 1993; 329: 271-272.
27. Khaw K-T. Where are all the women in studies of coronary disease? Br Med J 1993; 306: 1145-1146.
28. Wenger NO, Speroff L, Packard B. Cardiovascular Health and disease in women N Engl J Med 1993; 329: 247-256.
29. Petticrew M, McKee M, Jones J. Coronary artery surgery: Are women discriminated against? BMJ 1993; 306: 1164-1166.
30. Ayanian JO, Epstein AM. Differences in the use of procedures between men and women hospitalised for coronary artery disease N Engl J Med 1991; 325: 221-225.
31. Macintosh OF, Boyle RUM. Reasons for delay in permanent pacemaker insertion J Roy Coll Physicians 1986; 30: 220-221.
32. Khan SS et al. Increased mortality of women with coronary artery bypass surgery: evidence for referral bias Ann Intern Med 1990; 112: 561-571.
33. Clarke KW, Gray D, Keating NA, Hampton JR. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1993; 309: 563-566.
34. Sharp I (ed). Attitudes to women and coronary heart disease. In: Coronary Heart Disease: Are Women Special? National Forum for CHD Prevention: London, 1994, pp. 25-45.
35. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care Eur Heart J 1991; 12: 315-321.
36. McDermott MM, Feinglass J, Sy J, Gheorghiade M. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy Am J Med 1995; 99: 629-635.
37. Psaty BM et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study Ann Epidemiol 1995; 5: 270-277.
38. Marmot M, Brunner EJ. CHD risk among women: Whitehall II and other studies. In Coronary Heart Disease: Are Women Special? National Forum for CHD Prevention: London 1994; pp 57-70.
39. Rogers WJ, Johnstone DF, Yusuf S for the SOLVD investigators. Quality of life among 5025 patients with left ventricular dysfunction randomised between placebo and enalapril J Am Coll Cardiol 1994; 23: 393-400.
40. Guyatt GH. Measurement of health-related quality of life in heart failure J Am Coll Cardiol 1993; 22: 185A-191A.
41. Rogers WE et al. Quality of life among 5025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. The SOLVD Investigators J Am Coll Cardiol 1994; 23: 393-400.
42. Gorkin L et al. Assessment of quality of life as observed from the baseline data of the studies of left ventricular dysfunction (SOLVD) trial Am J Cardiol 1993; 71: 1069-1073.
43. Dracup K, Walden JA, Stevenson LW, Brecht ML. Quality of life in patients with advanced heart failure J Heart Lung Transplant 1992; 11: 273-279.
44. Hawthorne MH, Hixon ME. Functional status, mood disturbance and quality of life in patients with heart failure Prog Cardiovasc Nurs 1994; 9: 22-32.
45. Coats AJ et al. Effects of physical training in chronic heart failure Lancet 1990; 335: 63-66.
46. Blackwood R et al. Exercise capacity and quality of life in the treatment of heart failure Clin Pharmacol Ther 1990; 48: 325-332.
47. Karmilovich SE. Burden and stress associated with spousal caregiving for individuals with heart failure Prog Cardiovasc Nurs 1994; 9: 33-38.
48. Rector TS et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. The V-HeFT VA Cooperative Studies Group Circulation 1993; 87: V171-V177.
49. Teo KK. et al. Contemporary medical management of left ventricular dysfunction and congestive heart failure Can J Cardiol 1992; 8: 611-619.
50. Jaeschke R, Oxman AD, Guyatt GH. To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis Am J Med 1990; 88: 279-286.
51. Yusuf S. Clinical experience in protecting the failing heart Clin Cardiol 1993; 16: II25-II29.
52. Yusuf S, Garg R, Held P, Gorlin R. Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure Am J Cardiol 1992; 69: 64G-70G.
53. The Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure Lancet 1990; 336: 1-6.
54. Doughty RN, MacMahon S, Sharpe N. Beta-blockers in heart failure: promising or proved? J Am Coll Cardiol 1994; 23: 814-821.
55. CONSENSUS. Effect of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 1987; 325: 351-353.
56. The SOLVD Investigators. The effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 1992; 327: 303-310.
57. Riegger GA. Lessons from recent randomized controlled trials for the management of congestive heart failure Am J Cardiol 1993; 71: 38E-40E.
58. Nony P et al. Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure Eur Heart J 1992; 13: 1101-1108.
59. Israili ZH, Hall WD. ACE inhibitors. Differential use in elderly patients with hypertension Drugs Aging 1995; 7: 355-371.
60. Kjekshus J. Arrhythmias and mortality in congestive heart failure Am J Cardiol 1990; 65: 42I-48I.
61. Cleland JG. The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials Eur Heart J 1994; 15: 125-130.
62. Paul SD, Kuntz KM, Eagle KA, Weinstein MC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure Arch Intern Med 1994; 154: 1143-1149.
63. Coats AJS. Therapeutic interventions to reduce rates of hospitalization and death in patients with heart failure: new clinical evidence Cardiol 1992; 81: 1-7.
64. Harries U, Landes R, Popay J. Visual disability among older people: a case study in assessing needs and examining services J Publ Health Med 1994; 16: 211-218.